急性脑卒中患者直接口服抗凝剂使用趋势。
Trends in direct oral anticoagulant use in patients presenting with acute stroke.
机构信息
Eastern Health Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
Department of Neuroscience, Box Hill Hospital, Eastern Health, Melbourne, Victoria, Australia.
出版信息
Intern Med J. 2022 Sep;52(9):1633-1637. doi: 10.1111/imj.15903.
Abstract
Acute ischaemic strokes occur despite the use of direct oral anticoagulants (DOACs). A retrospective review was conducted at a high-volume primary stroke centre over a 3-year period to assess the acute management of stroke presentations in patients prescribed DOACs. During the time period of the study, 103 of 195 anticoagulated stroke patients presented within the timeframe for thrombolysis and only 15 patients had DOAC plasma level assays performed. Of these 103, 5 received thrombolysis; however, DOAC level was not a factor in these cases.
摘要
尽管使用了直接口服抗凝剂（DOACs），仍会发生急性缺血性中风。在一家高容量的初级中风中心进行了为期 3 年的回顾性研究，以评估在使用 DOAC 处方的患者中风发作的急性管理。在研究期间，195 名接受抗凝治疗的中风患者中有 103 名在溶栓时间窗内出现，只有 15 名患者进行了 DOAC 血浆水平检测。在这 103 名患者中，有 5 名接受了溶栓治疗；然而，在这些情况下，DOAC 水平并不是一个因素。
相似文献
1
Trends in direct oral anticoagulant use in patients presenting with acute stroke.
Intern Med J. 2022 Sep;52(9):1633-1637. doi: 10.1111/imj.15903.
2
Safety of Endovascular Thrombectomy for Acute Ischaemic Stroke in Anticoagulated Patients Ineligible for Intravenous Thrombolysis.
Cerebrovasc Dis. 2018;46(5-6):193-199. doi: 10.1159/000493801. Epub 2018 Nov 1.
3
Ischaemic stroke and transient ischaemic attack on anticoagulants: outcomes in the era of direct oral anticoagulants.
Intern Med J. 2020 Jan;50(1):110-113. doi: 10.1111/imj.14652.
4
Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants.
Eur J Neurol. 2018 May;25(5):747-e52. doi: 10.1111/ene.13582. Epub 2018 Mar 9.
5
Direct Oral Anticoagulant Plasma Levels for the Management of Acute Ischemic Stroke.
Cerebrovasc Dis. 2019;48(1-2):17-25. doi: 10.1159/000502335. Epub 2019 Sep 4.
6
Trends in anticoagulant prescribing: a review of local policies in English primary care.
BMC Health Serv Res. 2020 Apr 3;20(1):279. doi: 10.1186/s12913-020-5058-1.
7
The neurologist's approach to cerebral infarct and transient ischaemic attack in patients receiving anticoagulant treatment for non-valvular atrial fibrillation: ANITA-FA study.
Eur J Neurol. 2019 Feb;26(2):230-237. doi: 10.1111/ene.13792. Epub 2018 Sep 24.
8
Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis.
J Med Econ. 2022 Jan-Dec;25(1):1085-1091. doi: 10.1080/13696998.2022.2116848.
9
Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis.
Stroke. 2020 Feb;51(2):533-541. doi: 10.1161/STROKEAHA.119.026426. Epub 2019 Dec 30.
10
The relationship between stroke severity and prior direct oral anticoagulant therapy in patients with acute ischaemic stroke and non-valvular atrial fibrillation.
Eur J Neurol. 2017 Nov;24(11):1399-1406. doi: 10.1111/ene.13405. Epub 2017 Sep 5.
引用本文的文献
1
Urine-based point-of-care testing for factor-Xa-inhibitors in acute ischemic stroke patients: a feasibility study.
Front Neurol. 2023 Dec 15;14:1330421. doi: 10.3389/fneur.2023.1330421. eCollection 2023.
本文引用的文献
1
Low Exposure to Direct Oral Anticoagulants Is Associated with Ischemic Stroke and Its Severity.
J Stroke. 2022 Jan;24(1):88-97. doi: 10.5853/jos.2020.04952. Epub 2022 Jan 31.
2
Plasma levels of direct oral anticoagulants in atrial fibrillation patients at the time of embolic stroke: a pilot prospective multicenter study.
Eur J Clin Pharmacol. 2022 Apr;78(4):557-564. doi: 10.1007/s00228-022-03280-8. Epub 2022 Jan 22.
3
Mild in Name but Not in Nature.
Stroke. 2021 Jun;52(6):2005-2006. doi: 10.1161/STROKEAHA.121.035003. Epub 2021 May 5.
4
Regional differences in the care and outcomes of acute stroke patients in Australia: an observational study using evidence from the Australian Stroke Clinical Registry (AuSCR).
BMJ Open. 2021 Apr 1;11(4):e040418. doi: 10.1136/bmjopen-2020-040418.
5
Rates of Potentially Inappropriate Dosing of Direct-Acting Oral Anticoagulants and Associations With Geriatric Conditions Among Older Patients With Atrial Fibrillation: The SAGE-AF Study.
J Am Heart Assoc. 2020 Mar 17;9(6):e014108. doi: 10.1161/JAHA.119.014108. Epub 2020 Mar 9.
6
Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation.
Ann Neurol. 2020 Feb 12;87(5):677-87. doi: 10.1002/ana.25700.
7
Ischaemic stroke and transient ischaemic attack on anticoagulants: outcomes in the era of direct oral anticoagulants.
Intern Med J. 2020 Jan;50(1):110-113. doi: 10.1111/imj.14652.
8
Direct oral anticoagulant monitoring: what laboratory tests are available to guide us?
Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):194-197. doi: 10.1182/hematology.2019000027.
9
Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke.
N Engl J Med. 2019 May 9;380(19):1795-1803. doi: 10.1056/NEJMoa1813046.
10
Laboratory measurement of apixaban using anti-factor Xa assays in acute ischemic stroke patients with non-valvular atrial fibrillation.
J Thromb Thrombolysis. 2018 Feb;45(2):250-256. doi: 10.1007/s11239-017-1590-1.
Zotero 插件